Article
Mutated IgHV1-69 gene usage represents a distinct subgroup associated with indolent disease in chronic lymphocytic leukemia.
Leukemia & lymphoma - 1 Apr 2008
Galligan Leeona, Catherwood Mark A, Matthews Christine, Morris T C M 'Curly', Alexander H Dennis
Abstract excerpt
Biased IgHV gene usage in chronic lymphocytic leukemia (CLL) is well documented and suggests antigen involvement in leukemogenesis. IgHV1-69 is one of the most frequently rearranged IgHV genes in CLL and the majority of IgHV1-69 cases lack somatic hypermutation and display poor prognosis. However, its independent prognostic impact remains uncertain given reports showing a low proportion of mutated IgHV1-69 cases...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
